AOD-9604
hGH fragment 176-191
The C-terminal lipolytic fragment of human growth hormone, without the growth-promoting or insulin-antagonising regions of the parent molecule.
Current lot verified
CP-AOD9604-2607A · tested Jul 14, 2026
99.30 %
HPLC purity
About AOD-9604
AOD-9604 is a 16-residue fragment corresponding to residues 176-191 of human growth hormone, with an added tyrosine at the N-terminus. The interest in the fragment is separability: the lipolytic activity attributed to growth hormone maps to this C-terminal region, while the growth-promoting and insulin-antagonising activities map elsewhere in the molecule. A fragment that retains one and not the other is a useful tool for dissecting which effects belong to which domain.
It is a short, well-behaved peptide with a disulfide bridge between the two cysteines, and correct disulfide formation is the main quality variable. Our release panel includes a reduced-versus-non-reduced HPLC comparison to confirm the bridge actually formed rather than assuming it.
Published research areas
- Lipolysis and adipocyte models
- Growth hormone structure-function
- Fragment pharmacology
Specifications
- CAS number
- 221231-10-3
- Molecular formula
- C78H123N23O23S2
- Molecular weight
- 1815.10 g/mol
- Release specification
- ≥ 98.0 % by HPLC
- Appearance
- White lyophilised powder
- Solubility
- Readily soluble in sterile water
- Storage
- -20 °C lyophilised; 2–8 °C reconstituted
- Format
- lyophilized vial
Sequence
H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH (Cys7-Cys14 disulfide)
Handling and reconstitution
Avoid reducing agents in the diluent — they will open the Cys7-Cys14 bridge and change the molecule.
Storage: -20 °C lyophilised; 2–8 °C reconstituted
Full reconstitution and storage referenceLot history
Every released lot of this compound, oldest kept on file. Average across 2 lots: 99.12 %.
| Lot | Strength | Purity | Tested | Laboratory | |
|---|---|---|---|---|---|
| CP-AOD9604-2607A | 5 mg | 99.30 % | Jul 14, 2026 | Aurum Bioanalytics | Certificate → |
| CP-AOD9604-2605B | 10 mg | 98.93 % | May 1, 2026 | Janoshik Analytical | Certificate → |
Others in GLP & Metabolic
GLP & Metabolic
GLP-3 (RT)
Triple GIP/GLP-1/glucagon receptor agonist
From
$135



